## Introduction
Cell-free protein synthesis (CFPS) represents a paradigm shift in biotechnology, harnessing the complex molecular machinery of transcription and translation in a test tube, free from the constraints of living cells. This open, controllable environment provides unprecedented speed and precision, allowing engineers to directly interact with the core processes of life. By removing the need to maintain cell viability, CFPS overcomes major bottlenecks associated with traditional *in vivo* approaches, such as long turnaround times, the toxicity of certain products, and the difficulty of characterizing genetic parts in the complex milieu of a living organism.

This article serves as a graduate-level guide to understanding and applying [cell-free systems](@entry_id:264776) for modern [biological engineering](@entry_id:270890). It addresses the need for a cohesive framework that connects fundamental biochemical principles to practical, high-impact applications. By moving from molecular mechanisms to system-[level dynamics](@entry_id:192047) and real-world implementation, you will gain the knowledge required to design, optimize, and troubleshoot cell-free reactions for your own research goals.

The material is structured to build your expertise progressively. The first chapter, "Principles and Mechanisms," lays the foundation by deconstructing the cell-free system into its core components, from extract preparation and [energy metabolism](@entry_id:179002) to the subtleties of [resource competition](@entry_id:191325) and [codon usage](@entry_id:201314). With these fundamentals in place, the "Applications and Interdisciplinary Connections" chapter explores how CFPS is revolutionizing fields like synthetic biology, [biomanufacturing](@entry_id:200951), and diagnostics, integrating principles from engineering and materials science. Finally, the "Hands-On Practices" section challenges you to apply these concepts to solve quantitative problems, solidifying your understanding of the key parameters that govern system performance.

## Principles and Mechanisms

### Core Composition of Cell-Free Systems: From Extracts to Reconstituted Systems

Cell-free [protein synthesis](@entry_id:147414) (CFPS) harnesses the fundamental machinery of the [central dogma](@entry_id:136612)—[transcription and translation](@entry_id:178280)—outside the confines of a living cell. To achieve this, a reaction must be supplied with a minimum set of molecular components. These can be categorized into subsystems: a transcription subsystem ($S_{\mathrm{tx}}$) including RNA polymerase (RNAP), nucleotide triphosphates (NTPs), and a DNA template; a translation subsystem ($S_{\mathrm{tl}}$) comprising ribosomes, transfer RNAs (tRNAs), aminoacyl-tRNA synthetases (aaRSs), protein-based initiation, elongation, and [release factors](@entry_id:263668) (IFs/EFs/RFs), and amino acids; an energy subsystem ($S_{\mathrm{E}}$) providing adenosine triphosphate (ATP), [guanosine triphosphate](@entry_id:177590) (GTP), and a means of their regeneration; and an ionic/buffer subsystem ($S_{\mathrm{ion}}$) to maintain optimal concentrations of ions like magnesium ($Mg^{2+}$) and potassium ($K^{+}$) and to stabilize pH.

There are two principal philosophies for assembling these components: a "top-down" approach using crude cell extracts and a "bottom-up" approach using fully reconstituted systems.

#### Extract-Based Cell-Free Systems

The most common and historically significant approach to CFPS relies on the preparation of a crude cell lysate, or **extract**. This method involves growing a source organism, typically *Escherichia coli*, to a specific density, harvesting the cells, and then lysing them to release their cytoplasmic contents. The resulting lysate is then processed to generate a stable and active system. A standard procedure yields what is known as an **S30 extract**, referring to the supernatant collected after a [centrifugation](@entry_id:199699) step at $30,000 \times g$.

The preparation of a high-activity S30 extract is a multi-step process, with each stage having a distinct biochemical rationale [@problem_id:2718423].
1.  **Growth and Harvest**: Cells are typically grown to the mid-to-late exponential phase. At this stage of rapid growth, the cellular concentration of ribosomes and other translational machinery is maximal, enriching the final extract with these essential components. The cells are then rapidly cooled and harvested, usually by [centrifugation](@entry_id:199699). Performing this and subsequent steps on ice is critical to arrest metabolism and minimize the activity of endogenous proteases and nucleases that could degrade the synthetic machinery.
2.  **Lysis**: The harvested cell pellet is resuspended in a buffer and lysed using mechanical means, such as a French press or sonication. This physically disrupts the cell wall and membrane, releasing the entire soluble content of the cytoplasm.
3.  **Run-off Reaction**: The crude lysate is incubated at a physiological temperature (e.g., $37\,^{\circ}\mathrm{C}$) for 30-60 minutes. This crucial step, known as the **run-off reaction**, allows ribosomes that were actively translating endogenous messenger RNAs (mRNAs) at the moment of lysis to complete synthesis and "run off" the end of their templates. Once exposed, these endogenous mRNAs are rapidly degraded by native ribonucleases. The purpose of this step is twofold: it significantly reduces background [protein synthesis](@entry_id:147414) from host genes, and, most importantly, it liberates the entire ribosome pool, making it available and competent to initiate translation on the desired, exogenously supplied DNA template.
4.  **Clarification**: The lysate is subjected to high-speed [centrifugation](@entry_id:199699) (e.g., at $30,000 \times g$) to pellet cell debris, membrane fragments, and the majority of the genomic DNA. The resulting supernatant is the S30 extract.
5.  **Dialysis**: The S30 extract is dialyzed against a large volume of a defined buffer. This step uses a [semipermeable membrane](@entry_id:139634) with a specific [molecular weight cutoff](@entry_id:184607) (e.g., $10$-$14$ kDa) that retains large macromolecules (ribosomes, enzymes, tRNAs) while allowing small molecules to diffuse out. This effectively removes endogenous amino acids, nucleotides, and inhibitory metabolic byproducts (such as acetate and inorganic phosphate) that have accumulated. Dialysis thus "resets" the chemical environment of the extract, preparing it for the addition of a defined mixture of amino acids and an energy source for the CFPS reaction.

In an extract-based system, the lysate endogenously provides the entire complex translation machinery ($S_{\mathrm{tl}}$) along with a vast array of other uncharacterized proteins, including chaperones, metabolic enzymes, and the aforementioned detrimental nucleases and proteases. The user then exogenously supplies the DNA template, amino acids, NTPs, and the energy subsystem.

#### Reconstituted Cell-Free Systems

In contrast to the top-down approach, a "bottom-up" strategy involves reconstituting the entire transcription-translation machinery from individually purified components. The most well-known of these is the **PURE (Protein synthesis Using Recombinant Elements) system**. In this system, every macromolecular component—including ribosomes, all necessary translation factors, a complete set of 20 aminoacyl-tRNA synthetases, and the RNA polymerase (typically bacteriophage T7 RNAP)—is purified to homogeneity and then mixed together in defined concentrations. The small-molecule substrates (amino acids, NTPs, salts) and an energy regeneration system are then added from pure chemical stocks.

#### A Comparative Analysis: Control versus Robustness

The fundamental difference between extract-based and PURE systems lies in their degree of compositional definition, which has profound implications for their use [@problem_id:2718395]. We can formalize this by considering a composition vector, $\mathbf{c}$, that lists the concentrations of all active components, and a term, $\phi_{\mathrm{unk}}$, representing the fraction of total activity attributable to unknown components.

In an **extract-based system**, the composition is largely undefined. The crude lysate contains thousands of different proteins at unknown and variable concentrations. This results in poor compositional control (the user cannot precisely set the elements of $\mathbf{c}$) and a significant contribution from unknown activities ($\phi_{\mathrm{unk}} > 0$). This undefined nature can lead to batch-to-batch variability and [confounding](@entry_id:260626) background reactions, which is a major drawback for sensitive or diagnostic applications. However, the presence of this complex metabolic background and auxiliary proteins often makes extracts more robust and capable of producing higher protein yields.

In the **PURE system**, every macromolecule is added in a known quantity, affording the user near-perfect compositional control over $\mathbf{c}$. By design, the system contains no uncharacterized background enzymes, meaning $\phi_{\mathrm{unk}} \approx 0$. This high degree of definition makes the PURE system an invaluable tool for fundamental biochemical studies, for minimizing background noise in diagnostics, and for applications requiring the [incorporation of non-standard amino acids](@entry_id:200262) where competing native enzymes would be problematic. The trade-off is typically a higher cost and lower volumetric protein yield compared to extracts, a point we will explore in detail later.

### Programming Gene Expression: The Transcriptional Layer

The programmability of a cell-free system depends on the user's ability to introduce a specific genetic template and have it faithfully transcribed into mRNA. This involves choices about both the DNA template itself and the transcriptional machinery used to process it.

#### DNA Templates: Plasmids versus Linear DNA

Genetic information is typically introduced into a CFPS reaction as a DNA template, most commonly in the form of a circular plasmid or a linear DNA fragment generated by the [polymerase chain reaction](@entry_id:142924) (PCR). Each format presents distinct advantages and challenges [@problem_id:2718382].

**Circular plasmids** are inherently stable in *E. coli* extracts because they lack the free double-stranded ends that are recognized by endogenous exonucleases, such as the potent RecBCD complex. Furthermore, [bacterial transcription](@entry_id:174101) is often enhanced by the topology of the template. In living cells, DNA gyrase introduces **[negative supercoiling](@entry_id:165900)** into [plasmids](@entry_id:139477). This torsional stress stores free energy that facilitates the local unwinding of the DNA duplex at the promoter, lowering the energetic barrier for [transcription initiation](@entry_id:140735) by the native *E. coli* RNAP. While DNA gyrase is not typically active in CFPS, [plasmids](@entry_id:139477) purified from *E. coli* retain this supercoiling, often leading to higher expression levels.

**Linear DNA templates**, produced by PCR, offer the advantage of rapid generation without the need for cloning and plasmid purification. This makes them ideal for [rapid prototyping](@entry_id:262103). They also allow for precise control over the molar concentration of the template added to the reaction. However, their primary drawback is extreme vulnerability to degradation by exonucleases in crude extracts. An unprotected linear template may be destroyed within minutes, yielding little to no protein. To overcome this, several protection strategies have been developed:
*   **Chemical Modification**: Incorporating **[phosphorothioate](@entry_id:198118) linkages** in place of standard [phosphodiester bonds](@entry_id:271137) at the termini of the DNA fragment renders the ends resistant to nuclease cleavage.
*   **Protein-based Inhibition**: The addition of purified inhibitory proteins can protect linear DNA. A prime example is the **Gam protein** from [bacteriophage lambda](@entry_id:197497), which specifically binds to and inactivates the RecBCD nuclease complex. Another strategy is to add the **Ku protein**, a component of the eukaryotic non-homologous end-joining pathway, which binds with high affinity to double-stranded DNA ends and acts as a physical barrier.
*   **Steric Hindrance**: Bulky molecules can be attached to the DNA ends to physically block nuclease access. A common method is to use biotinylated PCR primers and then add **streptavidin**, which forms an exceptionally stable and large complex at the DNA termini.

When nuclease degradation is effectively mitigated, linear templates can achieve protein yields comparable to or even exceeding those from plasmids. It is crucial to note that DNA does not replicate in a standard CFPS reaction; the copy number of the template is fixed at the start of the experiment and is not influenced by plasmid-borne elements like the origin of replication [@problem_id:2718382].

#### Transcriptional Machinery: Orthogonality and Resource Partitioning

The choice of RNA polymerase and its corresponding promoter is a cornerstone of [synthetic circuit design](@entry_id:188989) in CFPS. While extracts contain the native *E. coli* multi-subunit RNAP, many systems are designed to use an exogenously added, high-efficiency polymerase, most commonly from the **[bacteriophage](@entry_id:139480) T7**. The distinct properties of these two enzymes allow for the creation of orthogonal transcriptional circuits [@problem_id:2718372].

The **E. coli RNAP [holoenzyme](@entry_id:166079)** (typically with the $\sigma^{70}$ specificity factor in extracts) recognizes specific promoter sequences characterized by conserved $-10$ and $-35$ elements. As discussed, its activity can be strongly influenced by DNA supercoiling. In bacteria, transcription is often physically and kinetically coupled to translation, an interaction mediated by contacts between the RNAP and the lead ribosome.

The **T7 RNAP**, by contrast, is a single-subunit enzyme that is structurally unrelated to its bacterial counterpart. Its key features are:
*   **Promoter Specificity**: It recognizes a highly specific, conserved T7 [promoter sequence](@entry_id:193654) and shows no [cross-reactivity](@entry_id:186920) with *E. coli* [promoters](@entry_id:149896). Conversely, the *E. coli* RNAP does not recognize the T7 promoter. This mutual non-recognition is the basis of **transcriptional orthogonality**: two [gene circuits](@entry_id:201900), one driven by a T7 promoter and the other by an *E. coli* promoter, can operate in parallel within the same reaction volume without transcriptionally interfering with one another.
*   **Processivity and Speed**: T7 RNAP is known for its exceptionally high [processivity](@entry_id:274928) and elongation rate, often several-fold faster than *E. coli* RNAP.
*   **Lack of Coupling**: As a heterologous enzyme, T7 RNAP lacks the specific interfaces for strong physical coupling to the *E. coli* ribosome.

Using a T7-based system for a gene of interest effectively creates an independent transcriptional channel. This not only provides orthogonality but also partitions a key resource: the T7-driven gene does not compete for the limited pool of endogenous *E. coli* RNAP. However, orthogonality at the transcriptional layer does not eliminate competition for all resources. The mRNAs produced by both T7 RNAP and *E. coli* RNAP are translated by the same finite pool of ribosomes, and both transcription processes consume NTPs from the same common supply. This competition for shared translational resources is a critical feature of all CFPS systems.

### The Engine of Synthesis: Energetics and Resource Management

Protein synthesis is one of the most energetically demanding processes in biology. A central challenge in designing and operating a CFPS reaction is to provide a sufficient and sustained supply of energy in the form of ATP and GTP.

#### The Energetic Cost of Translation

To understand the energy requirements, we can perform a detailed accounting of the high-energy phosphate bonds consumed for each amino acid added to a growing polypeptide chain during the elongation cycle [@problem_id:2718411]. The minimal cost, excluding initiation and termination, involves three key steps:

1.  **tRNA Charging (Aminoacylation)**: An aminoacyl-tRNA synthetase attaches the correct amino acid to its cognate tRNA. This reaction is driven by the hydrolysis of one ATP molecule to adenosine monophosphate (AMP) and inorganic pyrophosphate ($PP_i$).
    $$ \text{Amino Acid} + \text{tRNA} + \mathrm{ATP} \longrightarrow \text{Aminoacyl-tRNA} + \mathrm{AMP} + PP_i $$
    This cleavage of the bond between the $\alpha$ and $\beta$ phosphates is energetically equivalent to breaking two high-energy phosphoanhydride bonds. The subsequent, rapid hydrolysis of pyrophosphate ($PP_i \rightarrow 2 P_i$) by the enzyme [pyrophosphatase](@entry_id:177161) releases further energy and makes the charging reaction irreversible. Thus, this step consumes **two** high-energy phosphate bond equivalents per amino acid.

2.  **Aminoacyl-tRNA Delivery**: The charged tRNA is escorted to the A-site of the ribosome by Elongation Factor Tu (EF-Tu), which is active when bound to GTP. Upon correct [codon-anticodon pairing](@entry_id:264522), the ribosome stimulates EF-Tu to hydrolyze its bound GTP to GDP, releasing the tRNA into the A-site. This step consumes **one** high-energy bond equivalent.

3.  **Translocation**: After the peptide bond is formed (a reaction catalyzed by the ribosome itself without external energy input), Elongation Factor G (EF-G) binds and, through the hydrolysis of another molecule of GTP to GDP, powers the mechanical movement of the ribosome one codon down the mRNA. This step consumes **one** high-energy bond equivalent.

Summing these costs, the incorporation of a single amino acid into a polypeptide chain requires a minimum of **four** high-energy phosphate bond equivalents: two from ATP and two from GTP. Synthesizing a typical protein of 30 kDa (~273 amino acids) thus consumes over 1000 molecules of ATP/GTP, highlighting the immense energetic demand of CFPS.

#### Energy Regeneration Systems

Given this high cost, the initial pool of ATP and GTP in a reaction would be depleted in seconds. Therefore, a robust **energy regeneration system** is essential to convert the resulting ADP and GDP back into their triphosphate forms. The choice of energy source profoundly impacts the duration and yield of the reaction [@problem_id:2718413].

Common energy sources include **[phosphoenolpyruvate](@entry_id:164481) (PEP)** and **[creatine phosphate](@entry_id:169985) (CP)**. These are high-energy phosphate donors that can rephosphorylate ADP to ATP in a single enzymatic step (catalyzed by [pyruvate kinase](@entry_id:163214) and creatine kinase, respectively). These are considered **single-turnover** systems, as each molecule of the energy source generates approximately one molecule of ATP. Their primary drawback lies in the accumulation of byproducts. The PEP system produces pyruvate, an organic acid that can lower the reaction pH, while both systems lead to the net accumulation of inorganic phosphate ($P_i$), a potent inhibitor. Creatine phosphate often gives modestly higher yields than PEP because its byproduct, creatine, is less disruptive to pH.

A more advanced and effective strategy utilizes **maltodextrin** or glucose. This approach leverages the endogenous glycolytic enzymes present in an *E. coli* extract. It is a **multi-turnover** system where cellular enzymes catalytically break down glucose to generate ATP. The metabolism of one molecule of glucose via glycolysis can yield 2-3 molecules of ATP through [substrate-level phosphorylation](@entry_id:141112). Critically, the first step in this pathway, catalyzed by maltodextrin phosphorylase, consumes inorganic phosphate:
$$ (\text{Glc})_n + P_i \rightarrow (\text{Glc})_{n-1} + \text{G1P} $$
This provides a crucial dual advantage: it not only provides a sustained, high-yield source of ATP but also actively counteracts the accumulation of inhibitory phosphate. This mitigation of byproduct toxicity is a primary reason why maltodextrin- or glucose-fed systems can sustain [protein synthesis](@entry_id:147414) for much longer and achieve significantly higher final titers (e.g., $1.2 \ \text{mg/mL}$) compared to systems using PEP ($0.5 \ \text{mg/mL}$) or [creatine phosphate](@entry_id:169985) ($0.7 \ \text{mg/mL}$) [@problem_id:2718413].

#### Inhibitory Byproducts and Cofactor Depletion

The accumulation of inorganic phosphate ($P_i$) is a recurring theme that severely limits CFPS performance. The primary mechanism of this inhibition is the **[chelation](@entry_id:153301) of free magnesium ions** ($Mg^{2+}$) [@problem_id:2718370]. Magnesium is an essential cofactor for the translational machinery. It is required to maintain the [structural integrity](@entry_id:165319) of ribosomal RNA, for the correct assembly of the 70S ribosome, and the true substrates for polymerases and kinases are the magnesium-bound forms, Mg-ATP and Mg-GTP.

As [protein synthesis](@entry_id:147414) proceeds, the hydrolysis of ATP and GTP releases a large amount of $P_i$. At a typical reaction pH of 7.5, a significant fraction of this phosphate exists as the dianion $HPO_4^{2-}$. This species forms a complex with magnesium ($Mg^{2+} + HPO_4^{2-} \rightleftharpoons MgHPO_4^{0}$), effectively sequestering it from the solution.

The consequences can be quantified. For instance, in a batch reaction that starts with $12 \ \mathrm{mM}$ of free $Mg^{2+}$ and produces $1 \ \mathrm{mg/mL}$ of a 30 kDa protein, the total phosphate generated can be calculated to be over $36 \ \mathrm{mM}$. At pH 7.5, this leads to the formation of a sufficient amount of the magnesium-phosphate complex to reduce the final free $[Mg^{2+}]$ to approximately $6.26 \ \mathrm{mM}$ [@problem_id:2718370]. Such a drastic reduction in the concentration of this critical [cofactor](@entry_id:200224) can significantly slow or completely arrest translation, demonstrating a direct causal link between the energetic cost of protein synthesis and the eventual failure of the system.

### System-Level Dynamics: Competition, Limits, and Optimization

The performance of a cell-free system emerges from the complex interplay of all its constituent parts. Understanding these system-[level dynamics](@entry_id:192047) is key to troubleshooting, optimizing, and rationally designing CFPS-based applications.

#### Resource Competition for Translation

A core principle governing the behavior of CFPS is **[resource competition](@entry_id:191325)**. When multiple mRNA species are present in a reaction, they must compete for the finite pool of shared translational resources, most notably the ribosomes. The binding of a ribosome to one mRNA sequesters it, making it unavailable to translate other mRNAs. This creates a coupling between the expression levels of all genes in the system.

This competitive interaction can be described with a mathematical model derived from [mass-action kinetics](@entry_id:187487) [@problem_id:2718428]. Consider two mRNA species, $M_1$ and $M_2$, competing for a total ribosome pool $R_{tot}$. If we model translation as a reversible binding step followed by an irreversible catalytic step, we can derive an expression for the rate of production of protein $P_1$, denoted $v_1$:
$$ v_1 = \frac{d[P_1]}{dt} = k_{\mathrm{cat},1} [C_1] = k_{\mathrm{cat},1} \frac{[M_1]}{K_{M,1}} \frac{[R_{\mathrm{tot}}]}{1 + \frac{[M_1]}{K_{M,1}} + \frac{[M_2]}{K_{M,2}}} $$
Here, $k_{\mathrm{cat},1}$ is the catalytic rate of protein synthesis from the ribosome-mRNA complex $C_1$, and $K_{M,i}$ is a Michaelis-like constant for each mRNA, representing its affinity for the ribosome. This equation quantitatively captures the essence of competition: the production rate $v_1$ is inversely proportional to the term containing $[M_2]$, the concentration of the competing mRNA. Increasing the amount of a competing transcript will titrate ribosomes away from the transcript of interest, reducing its expression. This "burden" is a fundamental consideration in designing multi-[gene circuits](@entry_id:201900). For example, in a system with defined kinetic parameters and concentrations, this model can predict a specific production rate, such as $v_1 = 2.126 \ \text{nM s}^{-1}$ [@problem_id:2718428].

#### Explaining Performance Differences: Extract versus PURE Yields

The systems-level perspective helps to explain a key observation: why do "messy" crude extracts often produce higher volumetric yields than "clean" PURE systems? The answer lies in auxiliary functions and biophysical properties that are present in extracts but absent from minimal reconstituted systems [@problem_id:2718436].

*   **Metabolite Recycling and Energy Charge**: Crude extracts contain extensive [metabolic networks](@entry_id:166711), such as glycolysis and the [pentose phosphate pathway](@entry_id:174990). These pathways are not only efficient at regenerating ATP from ADP, but they also contain enzymes like [adenylate kinase](@entry_id:163872) and nucleoside-diphosphate kinase that robustly recycle AMP and GDP. This maintains a high **energy charge**—a measure of the energetic state of the system—which is critical for sustaining anabolic processes like translation. Minimal PURE systems often lack this broad recycling capacity, leading to a rapid decline in energy charge and accumulation of inhibitory AMP and GDP.
*   **Macromolecular Crowding**: The cytoplasm of a cell is a dense environment, with macromolecules occupying 20-30% of the volume. This **[macromolecular crowding](@entry_id:170968)** has a profound biophysical consequence known as the [excluded volume effect](@entry_id:147060). It reduces the available volume for other molecules, thereby increasing their effective concentrations (or chemical activities) and favoring association reactions. Key steps in translation, particularly the assembly of the initiation complex, are association reactions. The crowded environment of an extract therefore promotes higher rates of [translation initiation](@entry_id:148125) compared to the dilute conditions of a typical PURE system. Adding inert crowding agents (like polyethylene glycol, PEG) to PURE systems is a common strategy to increase their yields.
*   **Auxiliary Factors**: Extracts contain a host of beneficial auxiliary proteins absent in minimal PURE systems. These include protein **chaperones** (like DnaK/DnaJ/GrpE) that assist in the correct folding of newly synthesized polypeptides, preventing aggregation and increasing the yield of active protein.

In essence, the higher performance of crude extracts stems from their ability to better manage energy and byproducts, coupled with a biophysical environment and auxiliary protein cohort that are more conducive to high-level [protein synthesis](@entry_id:147414).

#### The Subtleties of Optimization: Codon Usage in CFPS

A final, powerful example of system-level thinking is the often-puzzling failure of *in vivo* [codon optimization](@entry_id:149388) strategies to improve CFPS yields [@problem_id:2718402]. Algorithms for [codon optimization](@entry_id:149388) typically replace [rare codons](@entry_id:185962) with synonymous ones that are frequently used in highly expressed genes of a fast-growing host, based on the assumption that the abundance of tRNAs is co-adapted with this usage. The goal is to maximize the elongation speed ($v_{\mathrm{elong}}$). This strategy can fail in CFPS for two principal reasons.

First, the underlying assumption about the tRNA pool is often invalid. A CFPS extract contains a **fixed tRNA pool** inherited from the cells at the time of lysis. Its composition and charging state may not match the dynamic tRNA profile of an exponentially growing cell for which the optimization was designed. Overusing a codon that is abundant *in vivo* but corresponds to a scarce or poorly charged tRNA in the extract can create a new translational bottleneck, slowing elongation and reducing yield.

Second, many CFPS reactions do not operate in an elongation-limited regime. Due to the high template concentrations often used and the finite pool of ribosomes and [initiation factors](@entry_id:192250), the system can become **initiation-limited**. The overall rate of protein production ($J$) is determined by the rate of initiation ($k_{\mathrm{init}}$), not the speed of the ribosomes traversing the mRNA. In this regime ($J \approx k_{\mathrm{init}}$), increasing the potential elongation speed is futile; it will not increase the number of proteins produced per unit time. The absence of growth-coupled regulatory feedback in CFPS means the system cannot respond to codon demand by synthesizing more of the required tRNAs or ribosomes, making these limitations absolute. This illustrates how optimizing one part of a system in isolation, without considering the system-level context and its true rate-limiting steps, can be an ineffective or even counterproductive strategy.